Effect of adding motolimod to standard combination chemotherapy and cetuximab treatment of patients with squamous cell carcinoma of the head and neck the ACTIVE8 randomized clinical trial

Robert L. Ferris, Nabil F. Saba, Barbara J. Gitlitz, Robert Haddad, Ammar Sukari, Prakash Neupane, John C. Morris, Krzysztof Misiukiewicz, Julie E. Bauman, Moon Fenton, Antonio Jimeno, Douglas R. Adkins, Charles J. Schneider, Assuntina G. Sacco, Keisuke Shirai, Daniel W. Bowles, Michael Gibson, Tobenna Nwizu, Raphael Gottardo, Kristi L. ManjarrezGregory N. Dietsch, James Kyle Bryan, Robert M. Hershberg, Ezra E.W. Cohen

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of adding motolimod to standard combination chemotherapy and cetuximab treatment of patients with squamous cell carcinoma of the head and neck the ACTIVE8 randomized clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences